Oak Longevity vs TMates: Price, doctors, and tirzepatide access
Oak Longevity vs TMates is primarily a choice between lower advertised prices and broader clinical access. Early verdict: Oak Longevity is the lower-cost option for compounded GLP-1s while TMates emphasizes 24/7 U.S. physician availability and nationwide licensing.
See Oak Longevity pricing and plans
How they differ at a glance
This comparison uses only stated provider facts. The most distinctive supported differences are price, tirzepatide availability, clinician access and supervision, subscription and billing model, and state coverage. Each point below compares Oak Longevity directly to TMates using the supplied evidence.
1. Price and pricing model
Oak Longevity advertises semaglutide from $133 per month and tirzepatide from $199 per month with one flat price for all dosages and no subscriptions or membership fees. TMates lists a flat $199 per month at every dose, described as the same price as dosage escalates, with published multi-month pricing tiers on its site.
2. Tirzepatide availability
Oak Longevity explicitly offers both compounded semaglutide and compounded tirzepatide, with tirzepatide starting at $199/month. TMates emphasizes semaglutide as its core offering; public detail on tirzepatide availability is limited in the supplied material and not stated as widely offered the way Oak lists it.
3. Clinician access and care model
Oak Longevity uses an asynchronous clinical review with no required video call; a licensed clinician reviews the online questionnaire. TMates highlights 24/7 access to U.S.-based doctors and virtual check-in appointments, presenting more continuous physician availability than asynchronous review.
View TMates doctor access details
4. Subscriptions, billing, and shipping
Oak Longevity states no subscriptions or membership fees and bills monthly on a non-recurring basis so patients choose to renew; three-month prescriptions are billed upfront and no refunds are available after physician approval and once medication has shipped. Oak also includes free shipping and free health coaching. TMates promotes free shipping and cancel anytime language in captured content and lists multi-month pricing tiers; the material also states both that TMates operates on a direct-pay model and that “In general yes, TMates accepts most major insurance plans,” which is part of the supplied evidence.
5. State coverage and formulation
TMates says it provides licensed coverage in all 50 states and that its medications are formulated in U.S.-based facilities. Oak Longevity notes treatment is available only when a licensed clinician determines it is medically appropriate and that compounded medications, when offered, are not FDA-approved; Oak availability by state is asked about on its site but full state listings are not provided in the supplied evidence.
Comparison table: Oak Longevity vs TMates
| Criteria | Oak Longevity | TMates |
|---|---|---|
| Semaglutide starting price | $133/mo | $199/mo flat |
| Tirzepatide | Offered, from $199/mo | Limited public detail in supplied material |
| Price model | One flat price for all dosages, no subscription | Flat $199/month at every dose, multi-month tiers shown |
| Clinician access | Asynchronous licensed clinician review, no video call required | 24/7 U.S.-based doctor access and virtual check-ins |
| Shipping and extras | Free shipping and free health coaching | Free shipping, virtual check-ins |
| State coverage | Available when licensed clinician determines medically appropriate; full state list not supplied | Licensed coverage in all 50 states as stated |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
What this means for prospective patients
If your main priority is lower advertised monthly cost for compounded semaglutide or access to tirzepatide, Oak Longevity is positioned as the lower-cost option with semaglutide from $133/mo and tirzepatide from $199/mo and emphasizes no subscriptions plus free coaching and shipping. If continuous physician availability and nationwide licensed coverage are critical, TMates promotes 24/7 U.S. doctor access and licensed coverage in all 50 states at a flat $199/mo rate.
Compare TMates medical support
Bottom line and how to choose
Oak Longevity vs TMates comes down to price and scope of medical access. Oak Longevity offers lower starting pricing and both semaglutide and tirzepatide in the supplied material, with an asynchronous clinician review and no subscription billing. TMates charges a flat $199 per month for semaglutide and highlights 24/7 U.S. doctor access and coverage in all 50 states.
Choose Oak Longevity if you want the lowest advertised monthly cost for compounded semaglutide, confirmed tirzepatide availability, no subscription, and free health coaching and shipping.
Choose TMates if you prioritize continuous 24/7 access to U.S.-based doctors and explicit nationwide licensing paired with a flat per-dose price.